Affecting millions of people globally, Alzheimer’s disease is a progressive brain disorder that slowly damages memory, thinking, and behavior. In its later stages, it can make simple daily tasks, like ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

In May 2025, the U.S. Food and Drug Administration cleared the first blood-based in vitro diagnostic test for AD, ...

The FDA-cleared tests aren’t designed for healthy, symptom-free people, but many people want this information anyway.